PROVEXIS PLC Logo

PROVEXIS PLC

Develops and licenses functional ingredients for the food and supplement markets.

PXS | IL

Overview

Corporate Details

ISIN(s):
GB00B0923P27
LEI:
21380042E3Y3N9VZ6N48
Country:
United Kingdom
Address:
2 BLAGRAVE STREET, RG1 1AZ READING

Description

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-21 14:50
Result of AGM
English 23.8 KB
2025-10-30 08:00
Final Results
English 388.4 KB
2025-09-30 09:40
Delay in publication of annual accounts
English 18.0 KB
2025-01-07 14:14
Grant of Options and Warrants
English 32.6 KB
2024-12-31 14:00
Total Voting Rights
English 13.8 KB
2024-12-31 10:59
Half-year Report
English 212.7 KB
2024-12-18 08:00
Purchase of Fruitflow® II SD & royalty payment
English 18.8 KB
2024-10-25 16:47
Result of AGM
English 24.2 KB
2024-09-30 08:00
Final Results
English 384.9 KB
2024-04-30 18:00
Total Voting Rights
English 13.7 KB
2024-03-28 08:00
Issue of Equity - purchase of Fruitflow® II SD
English 18.8 KB
2023-12-29 13:48
Half-year Report
English 198.4 KB
2023-10-26 14:51
Result of AGM
English 23.8 KB
2023-09-29 08:00
Final Results
English 374.8 KB
2023-08-30 08:04
BYHEALTH regulatory filing with Chinese SAMR
English 16.5 KB

Automate Your Workflow. Get a real-time feed of all PROVEXIS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PROVEXIS PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PROVEXIS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.